Pinned post
Reumatología Clinic
@Reumaclinic
Servicio de Reumatología Hospital Clinic, Barcelona
632 Following 3K Followers 1.2K Posts
Latest posts 5
Excited to participate in ACR Convergence 2026, sharing research on prescription patterns in RA-associated ILD @JC_SarmientoM &
Cause-specific mortality in SLE patients from Catalonia @DrGomezPuerta
Advancing through research & collaboration!
@hospitalclinic
#ACR26 #RAILD #SLE
Cause-specific mortality in SLE patients from Catalonia @DrGomezPuerta
Advancing through research & collaboration!
@hospitalclinic
#ACR26 #RAILD #SLE
Activa participación en el 30 congreso de la @seiomm en Murcia
-Que aporta el TBS @helena_florezz
-Marcadores de remodelado. Dra Peris
-IA e investigación @JC_SarmientoM
#osteoporosis #SEIOMM
-Que aporta el TBS @helena_florezz
-Marcadores de remodelado. Dra Peris
-IA e investigación @JC_SarmientoM
#osteoporosis #SEIOMM
Ianalumab for the Treatment of Patients with Sjögren’s Disease
NEPTUNUS 1 & 2 Trial.
Ianalumumab 300 mg monthly achieved greater decreased in ESSDAI at week 48 than placebo
Serious adverse events were similar
#sjogren
nejm.org/doi/full/10.10…
NEPTUNUS 1 & 2 Trial.
Ianalumumab 300 mg monthly achieved greater decreased in ESSDAI at week 48 than placebo
Serious adverse events were similar
#sjogren
nejm.org/doi/full/10.10…
D2T-RA session by Prof György Nagy from @semmelweishu in our weekly grand round
-defining D2TRA
-identifying comorbidities, CV risk & ILD
-recognizing CNS involvement
-exploring CAR-T cell therapies & -integrating non-pharmacological strategies
#D2TRA #rheumatoidarthritis
-defining D2TRA
-identifying comorbidities, CV risk & ILD
-recognizing CNS involvement
-exploring CAR-T cell therapies & -integrating non-pharmacological strategies
#D2TRA #rheumatoidarthritis